West Pharma (WST) Tops Q2 EPS by 33c, provides guidance
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $353.68 --0%
Revenue Growth %: +9.5%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +9.5%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q2 EPS of $1.84, $0.33 better than the analyst estimate of $1.51. Revenue for the quarter came in at $766.5 million versus the consensus estimate of $725.26 million.
GUIDANCE:
West Pharma sees FY2025 EPS of $6.65-$6.85, versus the consensus of $6.27.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PepsiCo (PEP) Misses Q2 EPS by 1c, Beats on Revenue
- Cognizant plans to train 5,000 AI engineers and 10,000 operators
- Citi names top picks in software ahead of Q2 earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
